Literature DB >> 12270237

Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms.

Shiroh Futaki1.   

Abstract

A basic peptide derived from the human immunodeficiency virus (HIV)-1 Tat has been reported to have the ability to translocate through the cell membranes and to bring exogenous proteins into the cells. We have demonstrated that these features were observable among many arginine-rich peptides including those having a branched chain structure. Based on these findings, the presence of a ubiquitous internalization mechanism for the arginine-rich peptides has been suggested. In this review, the potential of these peptides for the intracellular delivery of macromolecules and the mystery of the translocation mechanisms are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270237     DOI: 10.1016/s0378-5173(02)00337-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  39 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 2.  Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins.

Authors:  Lucian Soane; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

3.  Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases.

Authors:  Christina Foerg; Urs Ziegler; Jimena Fernandez-Carneado; Ernest Giralt; Hans P Merkle
Journal:  Pharm Res       Date:  2007-03-03       Impact factor: 4.200

4.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

Review 5.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

6.  Cell penetrating peptides: how do they do it?

Authors:  Henry D Herce; Angel E Garcia
Journal:  J Biol Phys       Date:  2008-05-15       Impact factor: 1.365

7.  Effects of employment of distinct strategies to capture antibody on antibody delivery into cultured cells.

Authors:  Kana Kuwahara; Kazuki Harada; Ryohei Yamagoshi; Takenori Yamamoto; Yasuo Shinohara
Journal:  Mol Cell Biochem       Date:  2015-02-20       Impact factor: 3.396

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

9.  Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Authors:  Christopher J Farrell; Jae Myun Lee; Eui-Cheol Shin; Marek Cebrat; Philip A Cole; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways.

Authors:  Yi Xu; Betty Revon Liu; Han-Jung Lee; Katie B Shannon; Jeffrey G Winiarz; Tien-Chun Wang; Huey-Jenn Chiang; Yue-wern Huang
Journal:  J Biomed Biotechnol       Date:  2010-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.